ABEONA THERAPEUTICS INC. Program Rights Obligations, Current
ABEONA THERAPEUTICS INC. (ABEO) had Program Rights Obligations, Current of $8.00 million as of 2020-04-17, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ProgramRightsObligationsCurrent · last filed 2023-03-29
- 2020-04-17: Program Rights Obligations, Current $8.00M.
- 2018-11-04: Program Rights Obligations, Current $3.00M.
| Period end | Program Rights Obligations, Current |
|---|---|
| 2020-04-17 | $8.00M 10-K · filed 2023-03-29 |
| 2018-11-04 | $3.00M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |